Aclaris Therapeutics (ACRS) Reports Q2 Loss of $0.62/Share

August 11, 2016 7:05 AM EDT
Get Alerts ACRS Hot Sheet
Price: $28.14 +0.18%

Today's EPS Names:
FUL, BMRA, PVTB, More
Trade ACRS Now!
Join SI Premium – FREE

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

Aclaris Therapeutics (NASDAQ: ACRS) reported Q2 EPS of ($0.62), versus ($1.52) reported last year.

For earnings history and earnings-related data on Aclaris Therapeutics (ACRS) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment